Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype.

Related Articles Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun. 2018 05 03;9(1):1777 Authors: Oh SC, Sohn BH, Cheong JH,…

View More Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype.

A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.

Related Articles A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis. Am J Hum Genet. 2018…

View More A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.

Population-level distribution and putative immunogenicity of cancer neoepitopes.

Related Articles Population-level distribution and putative immunogenicity of cancer neoepitopes. BMC Cancer. 2018 04 13;18(1):414 Authors: Wood MA, Paralkar M, Paralkar MP, Nguyen A, Struck…

View More Population-level distribution and putative immunogenicity of cancer neoepitopes.

Personalized molecular modeling for pinpointing associations of protein dysfunction and variants associated with hereditary cancer syndromes.

Related Articles Personalized molecular modeling for pinpointing associations of protein dysfunction and variants associated with hereditary cancer syndromes. Mol Genet Genomic Med. 2018 09;6(5):805-810 Authors:…

View More Personalized molecular modeling for pinpointing associations of protein dysfunction and variants associated with hereditary cancer syndromes.

Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay.

Related Articles Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay. Diagn Pathol.…

View More Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay.

A response to the Chief Medical Officer’s report on Genomic Medicine: a catalyst for transformation.

Related Articles A response to the Chief Medical Officer’s report on Genomic Medicine: a catalyst for transformation. Per Med. 2018 01;15(1):5-8 Authors: Barwell J, Shaw…

View More A response to the Chief Medical Officer’s report on Genomic Medicine: a catalyst for transformation.

Mutations in the Epithelial Cadherin-p120-Catenin Complex Cause Mendelian Non-Syndromic Cleft Lip with or without Cleft Palate.

Related Articles Mutations in the Epithelial Cadherin-p120-Catenin Complex Cause Mendelian Non-Syndromic Cleft Lip with or without Cleft Palate. Am J Hum Genet. 2018 06 07;102(6):1143-1157…

View More Mutations in the Epithelial Cadherin-p120-Catenin Complex Cause Mendelian Non-Syndromic Cleft Lip with or without Cleft Palate.

Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma.

Related Articles Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma. BMC Cancer. 2018 Sep 21;18(1):911 Authors: Zhong…

View More Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma.

Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).

Related Articles Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).…

View More Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).

Identification of a novel DNMT1 mutation in a Chinese patient with hereditary sensory and autonomic neuropathy type IE.

Related Articles Identification of a novel DNMT1 mutation in a Chinese patient with hereditary sensory and autonomic neuropathy type IE. BMC Neurol. 2018 Oct 20;18(1):174…

View More Identification of a novel DNMT1 mutation in a Chinese patient with hereditary sensory and autonomic neuropathy type IE.